-
2
-
-
0027379018
-
Tretinoin toxicity in children with acute promyelocytic leukaemia
-
Mahmoud HH, Hurwitz CA, Roberts WM, et al. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet. 1993;342:1394.
-
(1993)
Lancet
, vol.342
, pp. 1394
-
-
Mahmoud, H.H.1
Hurwitz, C.A.2
Roberts, W.M.3
-
3
-
-
0030678635
-
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha 2a in pediatric patients with refractory cancer
-
Adamson PC, Reaman G, Finklestein JZ, et al. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha 2a in pediatric patients with refractory cancer. J Clin Oncol. 1997;15:3330-7.
-
(1997)
J Clin Oncol
, vol.15
, pp. 3330-3337
-
-
Adamson, P.C.1
Reaman, G.2
Finklestein, J.Z.3
-
4
-
-
0032838866
-
Pseudotumour cerebri in acute promyelocytic leukemia: Improvement despite continued ATRA therapy
-
Naderi S, Nukala S, Marreunda F, et al. Pseudotumour cerebri in acute promyelocytic leukemia: improvement despite continued ATRA therapy. Ann Hematol. 1999;78:333-4.
-
(1999)
Ann Hematol.
, vol.78
, pp. 333-334
-
-
Naderi, S.1
Nukala, S.2
Marreunda, F.3
-
5
-
-
84890921898
-
-
Accessed at March 1, 2010
-
Pfizer. Vfend: product monograph. Accessed at http://media.pfizer.com/ files/products/uspi-vfend.pdf, March 1, 2010.
-
Vfend: Product Monograph
-
-
-
6
-
-
0033674630
-
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principle metabolites
-
Marill J, Cresteil T, Lanotte M, Chabot G. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principle metabolites. Mol Pharmacol. 2000;58:1341-8.
-
(2000)
Mol Pharmacol.
, vol.58
, pp. 1341-1348
-
-
Marill, J.1
Cresteil, T.2
Lanotte, M.3
Chabot, G.4
-
7
-
-
34547663626
-
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects
-
Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391-6.
-
(2007)
Am Fam Physician.
, vol.76
, pp. 391-396
-
-
Lynch, T.1
Price, A.2
-
8
-
-
0038559875
-
Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia
-
Vanier KL, Mattiussi AJ, Johnston DL. Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2003;25:403-4.
-
(2003)
J Pediatr Hematol Oncol.
, vol.25
, pp. 403-404
-
-
Vanier, K.L.1
Mattiussi, A.J.2
Johnston, D.L.3
-
9
-
-
0027524546
-
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole
-
Rigas JR, Francis PA, Muindi JR, et al. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst. 1993;85:1921-6.
-
(1993)
J Natl Cancer Inst.
, vol.85
, pp. 1921-1926
-
-
Rigas, J.R.1
Francis, P.A.2
Muindi, J.R.3
-
10
-
-
32144432801
-
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole
-
Bennett MT, Sirrs S, Yeung JK, Smith CA. Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole. Leuk Lymphoma. 2005;46:1829-31.
-
(2005)
Leuk Lymphoma.
, vol.46
, pp. 1829-1831
-
-
Bennett, M.T.1
Sirrs, S.2
Yeung, J.K.3
Smith, C.A.4
-
11
-
-
34247231457
-
Proposal for a new tool to evaluate drug interaction cases
-
Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-80.
-
(2007)
Ann Pharmacother.
, vol.41
, pp. 674-680
-
-
Horn, J.R.1
Hansten, P.D.2
Chan, L.N.3
-
12
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
-
(1981)
Clin Pharmacol Ther
, vol.30
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
|